Global Custom Market Research Reports Provider Company

phone

Aquinox Pharmaceuticals Inc (AQXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 24 Jul 2018
  • Number of Pages: 34
  • Category: Company Profile
  • Country: Canada
Summary

Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The companys lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a regualting component of the PI3K pathway. Its discovery platform is based on the screening of a natural product library of compounds to identify potential SHIP1 activators. Aquinox undertakes clinical trials of several drugs for the treatment of chronic obstructive pulmonary disease, bladder pain syndrome interstitial cystitis, allergic asthma and atopic dermatitis, among others. The company has operations in Canada and the US. Aquinox is headquartered in Vancouver, British Columbia, Canada.

Aquinox Pharmaceuticals Inc (AQXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData




Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Aquinox Pharma Raises US$18 Million In Series C Financing 10
Licensing Agreements 11
Astellas Pharma Enters into Licensing Agreement with Aquinox Pharma 11
Equity Offering 12
Aquinox Pharma Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 12
Aquinox Pharma Plans to Raise up to USD171.4 Million in Public Offering of Shares 1
Aquinox Pharma Raises USD57.7 Million in Public Offering of Shares 14
Aquinox Pharma Raises USD98 Million in Public Offering of Shares 16
Aquinox Pharma to Raise USD25 Million in Public Offering of Shares 18
Aquinox Pharma Completes IPO For US$5 Million 19
Aquinox Pharmaceuticals Inc - Key Competitors 21
Aquinox Pharmaceuticals Inc - Key Employees 22
Aquinox Pharmaceuticals Inc - Locations And Subsidiaries 2
Head Office 2
Other Locations & Subsidiaries 2
Recent Developments 24
Financial Announcements 24
May 08, 2018: Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results 24
Mar 12, 2018: Aquinox Pharmaceuticals Announces Year End 2017 Financial Results 26
Aug 08, 2017: Aquinox Pharmaceuticals Announces Second Quarter 2017 Financial Results 28
May 09, 2017: Aquinox Pharmaceuticals Announces First Quarter 2017 Financial Results 0
Mar 09, 2017: Aquinox Pharmaceuticals Announces Year End 2016 Financial Results 1
Corporate Communications
Mar 27, 2017: Aquinox Announces Appointment of Dr. Kelvin Neu and Dr. Richard Levy to Board of Directors
Appendix 4
Methodology 4
About GlobalData 4
Contact Us 4
Disclaimer 4

List Of Tables

List of Tables
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aquinox Pharma Raises US$18 Million In Series C Financing 10
Astellas Pharma Enters into Licensing Agreement with Aquinox Pharma 11
Aquinox Pharma Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 12
Aquinox Pharma Plans to Raise up to USD171.4 Million in Public Offering of Shares 13
Aquinox Pharma Raises USD57.7 Million in Public Offering of Shares 14
Aquinox Pharma Raises USD98 Million in Public Offering of Shares 16
Aquinox Pharma to Raise USD25 Million in Public Offering of Shares 18
Aquinox Pharma Completes IPO For US$53 Million 19
Aquinox Pharmaceuticals Inc, Key Competitors 21
Aquinox Pharmaceuticals Inc, Key Employees 22
Aquinox Pharmaceuticals Inc, Other Locations 23

List Of Figures

List of Figures
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate

View Report

US Physical Therapy Inc (USPh) operates outpatient physical and occupational therapy clinics that offer pre-and post-operative care. The company provides treatment for orthopedic-related disorders, preventative care, sports-related injuries, rehabilitation of

View Report

University of Copenhagen (UCPH) is a university and research institution that offers educational and research programs and services. The university services include graduate and undergraduate courses, research programs, masters programs,

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports